Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema in High Risk Patients

NCT01893879 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01893879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01893879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema in High Risk Patients
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2014
Completion date
April 30, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema, unspecified adult solid tumor, protocol specific